ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hillel Laks
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marelli, D.
Right arrow Articles by Moriguchi, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marelli, D.
Right arrow Articles by Moriguchi, J. D.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 2000;70:59-66
© 2000 The Society of Thoracic Surgeons

Original articles: Cardiovascular

Mechanical assist strategy using the BVS 5000i for patients with heart failure

Daniel Marelli, MDa, Hillel Laks, MDa, Daniel Fazio, BSa, Michele A. Hamilton, MDa, Gregg C. Fonarow, MDa, Deborah A. Meehan, MSNa, Jaime D. Moriguchi, MDa

a Division of Cardiothoracic Surgery, University of California Medical Center, Los Angeles, California, USA

Address reprint requests to Dr Marelli, Division of Cardiothoracic Surgery, UCLA School of Medicine, 10833 Le Conte Ave, 62-238 CHS, Box 951741, Los Angeles, CA 90095-1741
e-mail: dmarelli{at}mednet.ucla.edu

Background. The BVS 5000i external pulsatile assist device is used to support patients with reversible cardiogenic shock. Its low cost and potential for insertion without cardiopulmonary bypass make it an attractive option.

Methods. Nineteen status I patients failing inotropic support were treated with the BVS 5000i with the intention of short-term bridge to transplant. Fourteen patients received left ventricular support whereas 5 received biventricular support. Cardiopulmonary bypass was used in less than 50% of patients.

Results. Median support time was 7 days. The 2 myocarditis patients were weaned from support. Twelve patients were transplanted and there were 5 deaths on support. Overall 14 of 19 were transplanted or weaned. One-year survival was 79%. Median hospital stay was 31 days.

Conclusions. The BVS 5000i can be used for short-term mechanical assist toward transplantation in selected patients for whom a donor can be expected soon. The device may provide a cost-effective, short-term strategy to optimize end-organ function before orthotopic heart transplant, particularly for patients who are predictably not ideal to be discharged with implantable left ventricular assist device treatment.


Related Article

Invited commentary
Walter P. Dembitsky
Ann. Thorac. Surg. 2000 70: 66. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Card Surg AdultHome page
E. C. McGee Jr., P. M. McCarthy, and N. Moazami
Temporary Mechanical Circulatory Support
Card. Surg. Adult, January 1, 2008; 3(2008): 507 - 534.
[Full Text]

Home page
 Card Surg AdultHome page
J. M. Bailey, K. A. Tanaka, and J. H. Levy
Cardiac Surgical Pharmacology
Card. Surg. Adult, January 1, 2003; 2(2003): 85 - 118.
[Full Text]

Home page
 Card Surg AdultHome page
N. Moazami and P. M. McCarthy
Temporary Circulatory Support
Card. Surg. Adult, January 1, 2003; 2(2003): 495 - 520.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.